About Helix Insight
Clinical genetics laboratories spend days manually interpreting genetic variants -- cross-referencing databases, reviewing literature, and applying classification guidelines. We are building the infrastructure to reduce that to minutes, without compromising clinical accuracy.
Helix Insight brings enterprise-grade engineering to clinical genomics. Built on dedicated EU infrastructure, following ACMG/AMP standards, and designed from the ground up for the rigorous demands of clinical genetics workflows.
Leadership
Vladimir Mitev
Founder & CEO
Founded Helena Bioinformatics to solve a problem that costs lives through delay: geneticists spending days on variant interpretation that technology should handle in minutes. Every hour a laboratory spends on manual classification is an hour a patient waits for answers.
Helix Insight is built on that urgency -- engineering infrastructure where clinical accuracy and speed are not trade-offs, but requirements. The mission is straightforward: give every genetics laboratory, regardless of size, access to interpretation tools that were previously only available to the largest institutions.
Helena Bioinformatics
Helena Bioinformatics is a bioinformatics company based in Sofia, Bulgaria, focused on developing AI-powered tools for clinical genetics. The company was founded to address a critical bottleneck in genomic medicine: the manual, time-consuming process of variant interpretation that limits the capacity of genetics laboratories worldwide.
Our infrastructure is hosted on dedicated servers in Helsinki, Finland, ensuring full GDPR compliance and EU data residency. We follow Clean Architecture principles with comprehensive audit trails, encryption at rest and in transit, and role-based access control -- the same standards expected in enterprise telecommunications and financial systems.
Helix Insight integrates with established clinical databases including ClinVar, gnomAD, PubMed, HPO, OMIM, and dbNSFP, and follows ACMG/AMP classification guidelines. Every analysis produces a complete evidence trail that geneticists can review, validate, and use in clinical reports.
Interested in learning more or exploring a partnership?